Antimicrobial laser-activated sealants for combating surgical site infections.


Journal

Biomaterials science
ISSN: 2047-4849
Titre abrégé: Biomater Sci
Pays: England
ID NLM: 101593571

Informations de publication

Date de publication:
18 May 2021
Historique:
pubmed: 21 4 2021
medline: 21 5 2021
entrez: 20 4 2021
Statut: ppublish

Résumé

Surgical-site infections (SSIs) occur in 2-5% of patients undergoing surgery in the US alone, impacting 300 000-500 000 lives each year, and presenting up to 11 times greater risk of death compared to patients without SSIs. The most common cause of SSI is Staphylococcus aureus, and methicillin-resistant S. aureus (MRSA) is the most common pathogen in community hospitals. Current clinical devices used for approximating incisions and traumatic lacerations include sutures, adhesives, tapes, or staples with or without antimicrobial incorporation. However, current closure technologies may not provide adequate protection against infection, are susceptible to wound dehiscence, and can result in delayed biomechanical recoveries. Laser-activated tissue repair is a sutureless technique in which chromophore-loaded sealants convert laser light energy to heat in order to induce rapid tissue sealing. Here, we describe the generation and evaluation of laser-activated sealant (LASE) biomaterials, in which, indocyanine green (ICG), an FDA-approved dye, was embedded in a silk fibroin matrix and cast into films as wound sealants. Silk-ICG films were subjected to different near-infrared (NIR) laser powers to identify temperatures optimal for laser sealing of soft tissues. A mathematical model was developed in order to determine the photothermal conversion efficiency of LASEs following laser irradiation. NIR laser activation of silk-ICG LASEs increased the recovery of skin biomechanical strength compared to sutured skin in full-thickness incisional wounds in immunocompetent mice, and live animal imaging indicated persistence of silk-ICG LASEs over several days. LASEs loaded with the antibiotic vancomycin demonstrated higher efficacies for combating MRSA infections in a mouse model of surgical site infection compared to antibacterial sutures. Our results demonstrate that LASEs can be loaded with antimicrobial drugs and may serve as new multifunctional biomaterials for rapid tissue sealing, repair and surgical site protection following surgery.

Identifiants

pubmed: 33876069
doi: 10.1039/d0bm01438a
pmc: PMC9617567
mid: NIHMS1726332
doi:

Substances chimiques

Anti-Bacterial Agents 0
Anti-Infective Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3791-3803

Subventions

Organisme : NIBIB NIH HHS
ID : R01 EB020690
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI147279
Pays : United States

Références

Nat Protoc. 2011 Sep 22;6(10):1612-31
pubmed: 21959241
Clin Infect Dis. 2007 Sep 15;45 Suppl 3:S191-5
pubmed: 17712746
Spine J. 2009 Feb;9(2):142-6
pubmed: 18619911
Nat Biotechnol. 2001 Apr;19(4):316-7
pubmed: 11283581
Biomaterials. 2015 Oct;67:11-9
pubmed: 26197411
Infect Control Hosp Epidemiol. 2014 Sep;35 Suppl 2:S66-88
pubmed: 25376070
Infect Control Hosp Epidemiol. 2008 Sep;29(9):890-3
pubmed: 18785849
J Antimicrob Chemother. 2009 Sep;64(3):441-6
pubmed: 19608582
Cochrane Database Syst Rev. 2013 Nov 18;(11):CD010427
pubmed: 24242704
J Clin Transl Res. 2015 Sep 30;1(2):1-18
pubmed: 30873446
Eur J Clin Microbiol Infect Dis. 2014 Nov;33(11):1981-7
pubmed: 24907853
Cochrane Database Syst Rev. 2014 Feb 14;(2):CD010365
pubmed: 24526375
J Clin Microbiol. 2004 Jun;42(6):2398-402
pubmed: 15184410
Carbohydr Polym. 2019 Jan 15;204:223-231
pubmed: 30366534
Lasers Surg Med. 2004;35(3):201-5
pubmed: 15389735
Lasers Med Sci. 2009 Jul;24(4):667-71
pubmed: 18982404
Dalton Trans. 2014 Aug 14;43(30):11709-15
pubmed: 24950757
ACS Nano. 2013 Apr 23;7(4):2988-98
pubmed: 23530530
Lasers Med Sci. 2007 Mar;22(1):10-4
pubmed: 17115238
J Emerg Med. 2010 Jan;38(1):40-50
pubmed: 19264440
J Cosmet Laser Ther. 2010 Dec;12(6):296-302
pubmed: 21142740
Open Surg Oncol J. 2010;2(2):12-25
pubmed: 22924087
J Surg Res. 2012 Aug;176(2):701-7
pubmed: 22440935
ACS Biomater Sci Eng. 2015 Sep 14;1(9):805-815
pubmed: 33445258
Global Spine J. 2019 Apr;9(2):219-230
pubmed: 30984503
J Gastrointest Surg. 2017 May;21(5):896-903
pubmed: 28101722
J Biomed Opt. 2008 Jul-Aug;13(4):044032
pubmed: 19021359
JAMA Surg. 2017 Aug 01;152(8):784-791
pubmed: 28467526
Plast Reconstr Surg. 2015 Jan;135(1):151-159
pubmed: 25539303
Asian Spine J. 2016 Feb;10(1):176-83
pubmed: 26949475
Int J Low Extrem Wounds. 2010 Mar;9(1):10-5
pubmed: 20207618
Infect Control Hosp Epidemiol. 2016 Jan;37(1):88-99
pubmed: 26503187
Orthop Rev (Pavia). 2015 Sep 28;7(3):5900
pubmed: 26605028
World Neurosurg. 2015 May;83(5):816-23
pubmed: 25535069
Lasers Surg Med. 1989;9(5):490-6
pubmed: 2811572
Surg Neurol Int. 2017 Nov 01;8:269
pubmed: 29184720
ACS Appl Mater Interfaces. 2017 Feb 15;9(6):5128-5138
pubmed: 28106379
Cochrane Database Syst Rev. 2013 Aug 20;(8):CD009726
pubmed: 23963687
Lasers Surg Med. 2007 Oct;39(9):716-22
pubmed: 17960755
World Neurosurg. 2015 Jun;83(6):1051-2
pubmed: 25769485
Cancer Lett. 1995 Jan 6;88(1):15-9
pubmed: 7850768
J Bone Joint Surg Br. 1994 Jan;76(1):99-102
pubmed: 8300691
Arch Surg. 1973 Aug;107(2):206-10
pubmed: 4719566
Surgery. 2013 Jul;154(1):89-100
pubmed: 23809487
Langmuir. 2012 Jun 26;28(25):9807-15
pubmed: 22620850
Spine (Phila Pa 1976). 1991 Aug;16(8):981-4
pubmed: 1948385
Clin Infect Dis. 2007 Jun 15;44(12):1543-8
pubmed: 17516396
Infect Dis Clin North Am. 2011 Mar;25(1):135-53
pubmed: 21315998
Adv Wound Care (New Rochelle). 2015 Sep 1;4(9):560-582
pubmed: 26339534
Adv Mater. 2010 Oct 8;22(38):4313-6
pubmed: 20734385
ACS Appl Mater Interfaces. 2017 Feb 22;9(7):5683-5691
pubmed: 28152314
Eye (Lond). 2016 Oct;30(10):1389-1394
pubmed: 27367746
J Spinal Cord Med. 2007;30(5):441-51
pubmed: 18092559
Ann Surg. 2009 Apr;249(4):576-82
pubmed: 19300233
Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2722-9
pubmed: 12766079
Int J Cancer. 2012 Mar 1;130(5):1208-15
pubmed: 21484791
J Biomed Mater Res. 2002 Jan;59(1):1-11
pubmed: 11745531
Foot Ankle Spec. 2016 Feb;9(1):24-30
pubmed: 26130625
J Control Release. 2010 Jun 1;144(2):159-67
pubmed: 20138938
J Antibiot (Tokyo). 2011 Sep;64(9):625-34
pubmed: 21811264
Lasers Surg Med. 2018 Feb;50(2):143-152
pubmed: 28990678
Clin Infect Dis. 2011 Feb 1;52(3):e18-55
pubmed: 21208910

Auteurs

Russell Urie (R)

Chemical Engineering Program, School for Engineering of Matter, Transport, and Energy, Arizona State University, Tempe, AZ 85287, USA. rege@asu.edu.

Michelle McBride (M)

Biodesign Institute Center for Bioelectronics and Biosensors, Arizona State University, Tempe, AZ 85287, USA. shelley.haydel@asu.edu.

Deepanjan Ghosh (D)

Biological Design Graduate Program, Arizona State University, Tempe, AZ 85287, USA.

Ali Fattahi (A)

Chemical Engineering Program, School for Engineering of Matter, Transport, and Energy, Arizona State University, Tempe, AZ 85287, USA. rege@asu.edu.

Rajeshwar Nitiyanandan (R)

Biological Design Graduate Program, Arizona State University, Tempe, AZ 85287, USA.

John Popovich (J)

Biodesign Institute Center for Bioelectronics and Biosensors, Arizona State University, Tempe, AZ 85287, USA. shelley.haydel@asu.edu.

Jeffrey J Heys (JJ)

Chemical and Biological Engineering Department, Montana State University, Bozeman, MT 59717, USA.

Jacquelyn Kilbourne (J)

Department of Animal Care and Technologies, Arizona State University, Tempe, AZ 85287, USA.

Shelley E Haydel (SE)

Biodesign Institute Center for Bioelectronics and Biosensors, Arizona State University, Tempe, AZ 85287, USA. shelley.haydel@asu.edu and School of Life Sciences, Arizona State University, Tempe, AZ 85287, USA.

Kaushal Rege (K)

Chemical Engineering Program, School for Engineering of Matter, Transport, and Energy, Arizona State University, Tempe, AZ 85287, USA. rege@asu.edu and Biological Design Graduate Program, Arizona State University, Tempe, AZ 85287, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH